PT  - JOURNAL ARTICLE
AU  - Sarah V Williams
AU  - Tanimola Akande
AU  - Kaja Abbas
TI  - Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria
AID  - 10.1101/2022.01.24.22269771
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.24.22269771
4099  - http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269771.short
4100  - http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269771.full
AB  - Background Nigeria has a high proportion of underimmunised children in the world. We estimated the inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and healthcare characteristics among children aged 12-23 months in Nigeria using a social determinants of health perspective.Methods We conducted a systematic review focused on inequities in childhood immunisation in low- and middle-income countries to identify the social determinants of childhood immunisation. Using these determinants, we analysed basic vaccination coverage in Nigeria (1-dose BCG, 3-dose DTP-HepB-Hib (diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B), 3- dose polio, and 1-dose measles) of 6,059 children aged 12-23 months using the 2018 Nigeria Demographic and Health Survey.Results We identified social determinants of immunisation – household wealth, religion, and ethnicity (socioeconomic characteristics); region and place of residence (geographic characteristics); maternal age at birth, maternal education, and maternal household head status (maternal characteristics); sex of child, and birth order (child characteristics); antenatal care and birth setting (healthcare characteristics). While basic vaccination coverage was 31% (95% CI: 29–33), 19% (18–21) of children aged 12-23 months had received none of the basic vaccines. After controlling for background characteristics, there was a significant increase in the odds of basic vaccination by household wealth, living in an urban area, antenatal care, delivery in a health facility, maternal age and maternal education. Children of Fulani ethnicity in comparison to children of Igbo ethnicity had lower odds of receiving basic vaccinations.Discussion Children of Fulani ethnicity, living in rural areas, born in home settings, with young mothers living in the poorest households with no formal education and no antenatal care visits were associated with lower rates of basic vaccination in Nigeria. We recommend a proportionate universalism approach with targeted vaccination programmes proportionate to the level of disadvantage for addressing the immunisation barriers.HighlightsSocial determinants of childhood immunisation were identified via a systematic reviewVaccine equity in Nigeria were analysed from a social determinants of health perspectiveBasic vaccination coverage was 31% among children aged 12-23 months19% of children had received none of the basic vaccines given in the first year of lifeVaccination coverage among even the most advantaged groups was below target levelsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementKA is supported by the Vaccine Impact Modelling Consortium (OPP1157270).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee (Reference: 21600) of the London School of Hygiene & Tropical Medicine. For DHS surveys in general, the procedures and questionnaires are approved by the ICF Institutional Review Board (IRB), and the country-specific Demographic Health Survey (DHS) survey protocols are reviewed by the ICF IRB and an IRB in the host country.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://dhsprogram.com/data/ https://dhsprogram.com/data/